TY  - JOUR
AU  - Conde Gallego, Esther
AU  - Hernández, Susana
AU  - Sánchez, Elena
AU  - Regojo, Rita María
AU  - Camacho, Carmen
AU  - Alonso, Marta
AU  - Martínez, Rebeca
AU  - López-Ríos Moreno, Fernando
PY  - 2020
DO  - 10.5858/arpa.2020-0400-RA
SN  - 0003-9985
UR  - https://hdl.handle.net/20.500.14352/116551
T2  - Archives of pathology & laboratory medicine
AB  - Context.—Food and Drug Administration–approved TRK inhibitors with impressive overall response rates are now available for patients with multiple cancer types that harbor NTRK rearrangements, yet the identification of NTRK fusions remains a difficult...
LA  - eng
M2  - 1031
PB  - College of American Pathologists
TI  - Pan-TRK Immunohistochemistry: An Example-Based Practical Approach to Efficiently Identify Patients With NTRK Fusion Cancer
TY  - journal article
VL  - 145
ER  -